Alveolar Ridge Augmentation With Curcumin Combined With Xenograft

Ain Shams University

Status and phase: Not yet enrolling; Phase 4

Conditions: Horizontal Alveolar Bone Loss

Treatments: Drug: Curcumin

Study type: Interventional

Funder types: Other

Identifiers

NCT04971382

OMD2021-3-

Details and patient eligibility

About

A study was performed to investigate the effect of curcumin on the osteogenic differentiation of human periodontal ligament stem cells (hPDLSCs) and its underlying potential mechanism. The Results was that Curcumin at an appropriate concentration had no cytotoxicity and could promote osteogenic differentiation of the hPDLSCs

Full description

Patients will be selected from the outpatient clinic of Oral Medicine, Periodontology and Oral diagnosis Department, Faculty of Dentistry, Ain Shams University. The purpose of the study will be explained to all patients and an informed consent will be signed before the conduction of the study .The faculty research ethics committee will review the proposal.

The study will be conducted in the form of Patient Intervention Comparative Outcome (PICO) question (Patient "P", Intervention "I", Comparative "C", Outcome "O"). (Stone 2002) "P": Patient in the study will have enough alveolar ridge height ,suffering from missing from 1 to 3 upper maxillary anterior and /or premolar with insufficient alveolar ridge buccolingual (BL) width that interfere with conventional straight forward implant placement. The minimum BL width included in the study will be 4 mm. "I": Ridge splitting with interposition grafting with curcumin and particulate xenograft grafting. "C":Alveolar ridge splitting with interposition grafting with use of particulate xenograft alone without curcumin . "O":Clinical and radiographic outcome.

Enrollment: 18 estimated patients

Sex: All

Ages: 25 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and female with age range 25-45 years.
• Patient with enough alveolar ridge height, suffering from missing single or multiple maxillary anterior and /or premolar with insufficient alveolar ridge buccolingual (BL) width that interfere with conventional straight forward implant placement. The minimum BL width included in the study will be 4-5 mm to facilitate ridge splitting and expansion.
• Systemically free from any diseases as evidenced by Burket's oral medicine health history questionnaire.
• Patient available during follow up periods.

Exclusion criteria

• Smokers.
• Pregnant and breast feeding females.
• Patient unwilling to comply to oral hygienic instructions.
• Patients under any medication or medical condition that affect the bone quality.
• Vulnerable groups. (e.g decisions impaired individual).

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

18 participants in 2 patient groups

curcumin combined with particulate xenograft.

Experimental group

Description:

Curcumin will be used in combination with xenograft after ridge splitting surgery Curcumin is widely used in medicine due to medicinal properties, cost-effectiveness, and simple extraction from a turmeric plant that grows in different regions in the world. Recent evidences have shown that curcumin possesses multiple biological activities and pharmacological properties including anti-inflammation , antioxidation , anticancer , antimicrobial , and free radical scavenger effects

Treatment:

Drug: Curcumin

alveolar ridge splitting with use of particulate xenograft alone.

Active Comparator group

Description:

xenograft will be used alone after ridge splitting

Treatment:

Drug: Curcumin